Keyword: Sandoz


Sandoz Spin-off from Novartis to Start on October 4, 2023

25.09.2023 -

Novartis today confirmed the plan to spin off 100% of its generic drugs arm Sandoz, with trading of the new company’s shares as well as ADRs (American Depositary Receipts...


Sandoz in Biosimilars Pact with Just – Evotec Biologics

12.05.2023 -

As Novartis moves toward shedding generics subsidiary Sandoz, which it touts as a global leader in off-patent generic and biosimilar drugs, Sandoz has agreed a multi-year...


Sandoz Builds Biologics Plant in Slovenia

17.03.2023 -

Sandoz, the generics and biosimilars arm of Swiss drugmaker Novartis, has signed a Memorandum of Understanding to build a biologics production plant in Lendava, Slovenia...


Sandoz Invests in Extra European Antibiotic Capacity

09.11.2022 -

Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to spend an additional €50 million on raising European manufacturing capacity for finished...


Novartis to Shutter a Sandoz US Plant

09.09.2022 -

In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US...


Novartis Definitely Plans to Spin off Sandoz

29.08.2022 -

Novartis has finally confirmed definite plans to spin off its generic drugs arm Sandoz.


Sandoz Launches Generic Combigan Drops

19.04.2022 -

Novartis subsidiary Sandoz has launched a generic version of Combigan, the ocular hypertensiondrug made by AbbVie’s Allergan arm. The copy of the off-patent eye drops...


Private Equity Buyers Seen as Circling Sandoz

02.02.2022 -

US private equity firms Blackstone and Carlyle may make a joint offer for the Novartis generics unit Sandoz, Bloomberg reports. With six other possible bidders seen as...